Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Seidel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|April 2, 2013
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodiesUrsula J E Seidel, Patrick Schlegel, Peter Lang
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 1, 1997
Declining sex ratios in CanadaB B Allan, R Brant, J E Seidel, et al.
Cancer Immunology, Immunotherapy : CII|November 26, 2011
A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigensUrsula J E Seidel, Claudia C Oliveira, Margit H Lampen, et al.
Frontiers in Immunology|February 10, 2018
T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1<sup>b</sup> with TAP-Independent Peptides Are Semi-Invariant LymphocytesElien M Doorduijn, Marjolein Sluijter, Bianca J Querido, et al.
Oncotarget|November 9, 2016
CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cellsChristian B Schiller, Todd A Braciak, Nadja C Fenn, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|April 2, 2013
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodiesUrsula J E Seidel, Patrick Schlegel, Peter Lang
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 1, 1997
Declining sex ratios in CanadaB B Allan, R Brant, J E Seidel, et al.
Cancer Immunology, Immunotherapy : CII|November 26, 2011
A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigensUrsula J E Seidel, Claudia C Oliveira, Margit H Lampen, et al.
Frontiers in Immunology|February 10, 2018
T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1<sup>b</sup> with TAP-Independent Peptides Are Semi-Invariant LymphocytesElien M Doorduijn, Marjolein Sluijter, Bianca J Querido, et al.
Oncotarget|November 9, 2016
CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cellsChristian B Schiller, Todd A Braciak, Nadja C Fenn, et al.
Pageof 1